• Latest Posts

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

German Biotech Raises Record $270M Series A for Individualized Cancer Therapies

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

Swedish Biotech Pockets $6M as its Cancer Antibody Heads for the Clinic

In Depth 4 Jan 2018

A Crash Course in the Basics of Finance in Biotechnology

Swiss Biotech Gets $339M to Boost the Development of Drug Addiction Therapies

ADVERTISEMENT

The Biggest Biotech News of 2017: What Happened This Year?

Biota Beats: Music from the Microbiome

ADVERTISEMENT